Pc. Pintodoo et al., SHORT-TERM VS SUSTAINED INHIBITION OF PROXIMAL TUBULE NA,K-ATPASE ACTIVITY BY DOPAMINE - CELLULAR MECHANISMS, Clinical and experimental hypertension, 19(1-2), 1997, pp. 73-86
Dopamine (DA) produces a natriuresis attributed in part to inhibition
of Na,K-ATPase activity (NKA) in the proximal tubule (PCT), and impair
ment in this inhibition has been linked to several forms of hypertensi
on in animals. Here we examined whether the intracellular signaling me
chanisms involved are the same in the early and late phases of this ph
enomenon. DA (1 mu M) inhibited NKA similarly after 15 min (by 38%) or
180 min (by 36%) incubation, taken to represent short-term (ST) and s
ustained (Sd) pump regulation, respectively. Calphostin C, a specific
inhibitor of protein kinase C (PKC), completely blocked the ST action
of DA on NKA, whereas IP20, a specific inhibitor of protein kinase (PK
A), had no effect. In contrast, IP20 completely abolished the Sd (180
min) inhibition by DA, whereas calphostin C had only a partial or vari
able effect. The DA-1 agonist fenoldopam (which does not activate PKC
but increases cAMP) alone failed to inhibit the pump at 180 min (as it
does also in the short-term in PCT), suggesting that ST inhibition is
required for the Sd effect to occur. Furthermore, PTH1-34, a known ST
inhibitor of NKA suppressed the pump at 180 min (by 46%), but unlike
in the short-term, this effect was completely prevented by IP20. In co
ntrast, PTH3-34, which does not stimulate adenylyl cyclase or activate
PHA, caused only a small (19%) and variable Sd inhibition. In conclus
ion, short-term inhibition of the PCT pump by dopamine is mediated via
PKC, whereas the sustained inhibition requires the PKA pathway in add
ition to the ongoing PMC-mediated effect.